These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22107252)

  • 1. 14-day in vitro chemical stability of insulin lispro in the MiniMed Paradigm pump.
    Sharrow SD; Glass LC; Dobbins MA
    Diabetes Technol Ther; 2012 Mar; 14(3):264-70. PubMed ID: 22107252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
    DeFelippis MR; Bell MA; Heyob JA; Storms SM
    Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of insulin lispro in insulin infusion systems.
    Lougheed WD; Zinman B; Strack TR; Janis LJ; Weymouth AB; Bernstein EA; Korbas AM; Frank BH
    Diabetes Care; 1997 Jul; 20(7):1061-5. PubMed ID: 9203437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps.
    Mohnicke M; Blecher A; Beichert K; Bidlingmaier B; Todt EJ; Dette C; Rotthaeuser B; Mukherjee B
    J Pharm Sci; 2023 Apr; 112(4):963-973. PubMed ID: 36521561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stability of insulin aspart in simulated continuous subcutaneous insulin infusion using a MiniMed 508 insulin pump.
    Senstius J; Harboe E; Westermann H
    Diabetes Technol Ther; 2007 Feb; 9(1):75-9. PubMed ID: 17316101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps.
    Senstius J; Poulsen C; Hvass A
    Diabetes Technol Ther; 2007 Dec; 9(6):517-21. PubMed ID: 18034606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
    Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
    Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.
    McVey E; Keith S; Herr JK; Sutter D; Pettis RJ
    J Diabetes Sci Technol; 2015 Aug; 9(6):1282-91. PubMed ID: 26319228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of insulin Lispro, Aspart, and Glulisine with the Solo MicroPump, a novel miniature insulin pump.
    Senesh G; Bushi D; Neta A; Yodfat O
    J Diabetes Sci Technol; 2010 Jan; 4(1):104-10. PubMed ID: 20167173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
    Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
    Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.
    Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of U-10 and U-50 dilutions of insulin lispro.
    Stickelmeyer MP; Graf CJ; Frank BH; Ballard RL; Storms SM
    Diabetes Technol Ther; 2000; 2(1):61-6. PubMed ID: 11467323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannula occlusion with use of insulin lispro and insulin infusion system.
    Wright AW; Little JA
    Diabetes Care; 1998 May; 21(5):874-5. PubMed ID: 9589263
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrinsic fibrillation of fast-acting insulin analogs.
    Woods RJ; Alarcón J; McVey E; Pettis RJ
    J Diabetes Sci Technol; 2012 Mar; 6(2):265-76. PubMed ID: 22538135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration and Chemical Stability of Commercially Available Insulins: A High-Resolution Mass Spectrometry Study.
    Baechler F; Stettler C; Vogt B; Bally L; Groessl M
    Diabetes Technol Ther; 2020 Apr; 22(4):326-329. PubMed ID: 32031881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Guerci B; Meyer L; Sallé A; Charrié A; Dousset B; Ziegler O; Drouin P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2673-8. PubMed ID: 10443658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Kumareswaran K; Hovorka R
    Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
    Benbarka MM; Khalil AB; Beshyah SA; Marjei S; Awad SA
    Diabetes Technol Ther; 2010 Apr; 12(4):287-90. PubMed ID: 20210567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.